References
- Ayala M, Robledo NR, Lopez-Munguia A, Vazquez-Duhalt R. 2000. Substrate specificity and ionization potential in chloroperoxidase-catalyzed oxidation of diesel fuel. Environ Sci Technol. 34(13):2804–2809.
- Ayala M, Segovia L, Torres E. 2016. Halogenases: a biotechnological alternative for the synthesis of halogenated pharmaceuticals. Mini.Rev Med Chem. 16:1100–1111.
- Cavalieri E, Rogan E, Chakravarti D. 2004. The role of endogenous catechol quinones in the initiation of cancer and neurodegenerative diseases. In S. Helmut, P. Lester (Eds.), Methods in enzymology, Vol. 382, Quinones and quinone enzymes, Part B. New York, USA: Academic Press; pp. 293–319.
- Combalbert S, Hernandez-Raquet G. 2010. Occurrence fate and biodegradation of estrogens in sewage and manure. Appl Microbiol Biotechnol. 86:1671–1692.
- Deblonde T, Cossu-Leguille C, Hartemann P. 2011. Emerging pollutants in wastewater: a review of the literature. Int J Hyg Environ Health. 214:442–448.
- Díaz-Torres E, Gibson R, González-Farías F, Zarco-Arista AE, Mazari-Hiriart M. 2013. Endocrine disruptors in the Xochimilco wetland Mexico city. Water Air Soil Pollut. 224(6):1586–1597.
- Fent K, Weston AA, Caminada D. 2006. Ecotoxicology of human pharmaceuticals. Aquat Toxicol. 76:122–159.
- García-Zamora JL, León-Aguirre K, Quiroz-Morales R, Parra-Saldívar R, Gómez-Patiño MB, Arrieta-Baez D, Rebollar-Pérez G, Torres E. 2018. Chloroperoxidase-mediated halogenation of selected pharmaceutical micropollutants. Catalysts. 8(1):32–48.
- Liehr JG. 1983. 2-Fluoroestradiol. Separation from estrogenicity and carcinogenicity. Mol Pharmacol. 23:278–281.
- Liu X, Zhang F, Liu H, Burdette JE, Li Y, Overk CR, Pisha E, Yao J, van Breemen RB, Swanson SM, et al. 2003. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen equilenin. Chem Res Toxicol. 16:741–749.
- Mumbo J, Lenoir D, Henkelmann B, Schramm KW. 2013. Enzymatic synthesis of bromo- and chlorocarbazoles and elucidation of their structures by molecular modeling. Environ Sci Pollut Res. 20:8996–9005.
- Nakamura H, Shiozawa T, Terao Y, Shiraishi F, Fukazawa H. 2006. By-products produced by the reaction of estrogens with hypoclorous acid and their estrogen activities. Journal of Health Science. 52(2):124–131.
- Pezzella A, Lista L, Napolitano A, d'Ischia M. 2005. Tyrosinase-catalyzed oxidation of 17β-estradiol: structure elucidation of the products formed beyond catechol estrogen quinones. Chem Res Toxicol. 18:1413–1419.
- Salcedo K, Torres-Ramírez E, Haces I, Ayala M. 2015. Halogenation of β-estradiol by a rationally designed mesoporous biocatalyst based on chloroperoxidase. Biocatalysis. 1:33–43.
- Santen RJ, Yue W, Wang JP. 2015. Estrogen metabolites and breast cancer. Steroids. 99:61–66.
- Shaw PD, Hager LP. 1959. An enzymatic chlorination reaction. J Am Chem Soc. 81(4):1011–1012.
- Zhang F, Swanson SM, van Breemen RB, Liu X, Yang Y, Gu C, Bolton JL. 2001. Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks apurinic sites stable adducts and oxidized bases. Chem Res Toxicol. 14:1654–1659.